Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This is a slow burn, not a switch
GLP-1 agonists are powerful tools, but their use demands caution and responsible healthcare oversight
Key Characteristics Mechanism of Action Pharmacological Profile Direct Receptor Activation Binds to IGF-1 receptors on target tissues Stimulates glucose uptake and utilization Promotes protein synthesis and cellular proliferation Activates intracellular signaling pathways (PI3K/AKT) Anabolic Effects Promotes muscle hypertrophy and satellite cell activation Enhances collagen deposition and tissue repair Stimulates mitochondrial biogenesis Supports bone mineralization Anti-Catabolic Action Inhibits muscle breakdown (proteolysis) Reduces protein degradation during stress Maintains lean mass during caloric restriction Supports recovery from injury or illness Key Advantages Over Natural IGF-1 Clinical Pearls: Metabolic Modulation: IGF-1 LR3 enhances insulin sensitivity and nutrient partitioning, making it particularly valuable in metabolic syndrome and insulin resistance states
The complex, multi-factorial pathogenesis of SAH, with intertwined pathways, strongly suggests that single-agent therapies may be insufficient to achieve sustained clinical benefit [14,31]
US$ 28.25
US$ 28.13
US$ 26.85
US$ 25.38
US$ 22.17
US$ 24.27
US$ 22.53
